ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of life"

  • Abstract Number: 1254 • ACR Convergence 2025

    Symptom Burden and Treatment Experience in Fibromyalgia: Results From a National Patient Survey

    Lesley Arnold1, Zhao Yang2, Parul Houston2, Todd Grinnell2 and Daniel Clauw3, 1University of Cincinnati College of Medicine, Cincinnati, OH, 2Axsome Therapeutics, Inc, New York, NY, 3Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI

    Background/Purpose: Fibromyalgia (FM) is a chronic, widespread pain disorder driven by dysregulated central pain processing which substantially impairs daily function and quality of life. Approved…
  • Abstract Number: 0789 • ACR Convergence 2025

    Short Form 36 (SF-36) Health Survey Questionnaire in Health-Related Quality of Life Assessment in Patients with Inflammatory Myopathies

    Almurtada Razok1, Jasmin Taylor2, Ethan Ritz3, Kristin Wipfler4, Kaleb Michaud5 and Didem Saygin6, 1John H Stroger Jr Hospital of Cook County, Chicago, IL, 2Rush Medical College, Chicago, IL, 3Rush Research Informatics Core, Rush University Medical Center, Chicago, IL, 4FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 5University of Nebraska Medical Center, Omaha, NE, 6Rush University Medical Center, Chicago, IL

    Background/Purpose: Patients with idiopathic inflammatory myopathies (IIM) experience significant impairment in their health-related quality of life (QoL); however, there are currently no validated measures to…
  • Abstract Number: 2337 • ACR Convergence 2025

    A Mediation Analysis of Tofacitinib’s Effects on SF-36: The Roles of Fatigue, Pain, Stiffness, and Mobility in Ankylosing Spondylitis

    Xenofon Baraliakos1, Andrew G. Bushmakin2, Joseph C. Cappelleri2, Eleni Nikitopoulou3, You-Li Ling4, Mostafa Zayed5 and Jonathan Dominick Cicci6, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 2Pfizer Inc., Groton, CT, 3Pfizer Hellas, Athens, Greece, 4Pfizer Inc, New York, NY, USA, New York, NY, 5Pfizer Gulf FZ LLC, Dubai, United Arab Emirates, 6Pfizer Inc., New York, NY

    Background/Purpose: Mediation modeling is used to determine mechanisms underlying the relationship between independent and dependent variables via other explanatory variables (“mediators”). Fatigue, pain, and morning…
  • Abstract Number: 1487 • ACR Convergence 2025

    Whole Health Empowerment for Endotypes of Lupus (WHEEL) Program: User Testing Findings on Feasibility, Acceptability, and Opportunities for Intervention Refinement

    Jennifer Rogers1, Amanda Eudy2, Connor Drake3, Tamara Somers4, David Pisetsky5, Christie Clipper6, Ralph Snyderman7, Anna Batsakes6, Leigh Saner6, Dana Burshell3, Mithu Maheswaranathan4, Lisa Criscione-Schreiber4, Rebecca Sadun8, Nathaniel Harris5, Kai Sun8, Kelsey Dunn6, Jenny Herndon6, Vonne Jacobs6 and Megan Clowse9, 1Duke, Durham, NC, 2Duke University, Raleigh, NC, 3Duke University School of Medicine, Durham, 4Duke University School of Medicine, Durham, NC, 5Duke University Medical Center, Durham, NC, 6Duke University, Durham, 7Duke Center for Personalized Health Care, Durham, NC, 8Duke University, Durham, NC, 9Duke University, Chapel Hill, NC

    Background/Purpose: To improve quality of life (QoL) in individuals with SLE, we developed the Whole Health Empowerment for Endotypes of Lupus (WHEEL) program—a 4-month, biweekly,…
  • Abstract Number: 1253 • ACR Convergence 2025

    Patient Reported Outcome Measures: Assessing Resident Physician Acceptance of the Routine Assessment of Patient Index Data 3 Survey and its Impact on Physician-Patient Relationship

    Nisha Sapkota1, Chana Birnbaum2, Henna Levitansky2, Yevheniia Andriushchenko2, Saadia Malik2, Melissa Andrade2, Sarang Choi2 and Sima Terebelo2, 1Interfaith Medical Center, One Broolyn Health, Brooklyn, NY, 2Brookdale Hospital Medical Center, One Brooklyn Health, Brooklyn

    Background/Purpose: When treating patients with rheumatological conditions, building a strong physician-patient relationship plays an important role in determining disease outcomes. The Routine Assessment of Patient…
  • Abstract Number: 0767 • ACR Convergence 2025

    Quality of Life in Patients with Rheumatoid Arthritis with Foot and Ankle Involvement

    Egla Samantha Sanchez-Peralta1, Andrea Cantero-Castro2, Karina Deciderio-Pavon3, Jesús Gilberto Espinoza-Gámez3, Irasema Arcibar-Liceaga3, Carolina De Leon-Carrillo3, Angel Kevin Garza-Elizondo1, Ryan Jared Sanchez-De la Cruz3, Jesus Alberto Cardenas-de la Garza4, Dionicio A. Galarza-Delgado5, Diana E. Flores-Alvarado1 and Jorge Alberto Elizondo-Rodriguez2, 1Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, México, Monterrey, Nuevo Leon, Mexico, 2Traumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo Leon, Mexico, 3Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo Leon, Mexico, 4Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, México, Monterrey, Mexico, 5Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Foot and ankle involvement in patients with rheumatoid arthritis is a common yet often underexplored and underrecognized manifestation. This can negatively affect patients' quality…
  • Abstract Number: 2326 • ACR Convergence 2025

    Impact of Regular Exercise, Mobility Impairment, and Obesity on Quality of Life in Patients with Axial Spondyloarthritis: A Cross-Sectional Analysis from the Brazilian Registry of Spondyloarthritis

    Rafael Bassara Macedo1, Maria Eduarda Veiga2, Gustavo Resende3, Marcelo Pinheiro4, Claudia Marques5, Adriana Marinho6, Andressa Soares7, Cleandro Pires8, Débora Rodrigues9, Eduarda Souza10, Glaucio Castro11, Guilherme Bulbol12, Jamile Carneiro13, José Mauro Fernandes14, Manuella Ochtrop15, Maria Bernadete Gavi16, Michel Yazbek17, Nara Cavalcanti18, Natalia Machado19, Olivio Malheiro20, Rejane Vieira21, Ricardo Lage20, Rita Menin22, Rywka Golebiovski23, Sandra Ribeiro12, Thauana Oliveira23, Valquiria Diniz16, Percival Sampaio-Barros24 and Carla Saad2, 1Rheumatology Division, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil, 2Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Sao Paulo, Brazil, 3Hospital das Clinicas UFMG, Belo Horizonte, Brazil, 4UNIFESP/ EPM, São Paulo, São Paulo, Brazil, 5Hospital das Clinicas - Universidade Federal de Pernambuco - UFPE, Recife, Pernambuco, Brazil, 6Fundação Hospital do Acre - AC, Rio Branco, Brazil, 7Hospital Universitário da Universidade Federal de Santa Catarina (UFSC) - SC, Florianópolis, Brazil, 8UNB, Brasilia, Distrito Federal, Brazil, 9Fundação Hospital do Acre - AC, Rio Branco, Acre, Brazil, 10Faculdade de Medicina da Universidade Federal do Amazonas (UFAM) - AM, Manaus, Brazil, 11Hospital Governador Celso Ramos (HCR) - SC, Florianópolis, Santa Catarina, Brazil, 12Faculdade de Medicina da Universidade Federal do Amazonas (UFAM) - AM, Manaus, Amazonas, Brazil, 13Hospital de Base do Distrito Federal (HBDF) - DF, Brasilia, Distrito Federal, Brazil, 14Universidade Federal do Maranhão (UFMA) - MA, São Luiz, Maranhao, Brazil, 15Hospital Universitário Pedro Ernesto / UERJ - RJ, Rio de Janeiro, Rio de Janeiro, Brazil, 16Universidade Federal do Espírito Santo (UFES) - ES, Vitória, Espirito Santo, Brazil, 17Universidade Estadual de Campinas (UNICAMP) - SP, Campinhas, Sao Paulo, Brazil, 18Hospital das Clínicas da Universidade Federal de Pernambuco (UFPE) - PE, Recife, Pernambuco, Brazil, 19Universidade Fedral do Paraná (UFPR) - PR, Curitiba, Parana, Brazil, 20Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG) - MG, Belo Horizonte, Minas Gerais, Brazil, 21Universidade Estadual do Ceará (UECE) - CE, Fortaleza, Ceara, Brazil, 22Faculdade de Medicina de São José do Rio Preto (FAMERP) - SP, São José do Rio Preto, Sao Paulo, Brazil, 23Escola Paulista de Medicina (EPM) - Universidade Federal de São Paulo (UNIFESP) - SP, São Paulo, Sao Paulo, Brazil, 24Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, Brazil

    Background/Purpose: Axial Spondyloarthritis (axSpA) is a chronic inflammatory disease that impairs quality of life. While pharmacological treatment is central to axSpA management, non-pharmacological strategies are…
  • Abstract Number: 1461 • ACR Convergence 2025

    Digital Behavioral Therapy Improves Outcome in Patients With Axial Spondyloarthritis And Persistent Pain: Results From a Randomized Controlled Trial

    David Kiefer1, Yade Sonkaya2, Dietmar Krause3, Markus Voglau4, Bernhard Mintrop5, Imke Redeker6, Xenofon Baraliakos7 and Uta Kiltz7, 1Ruhr-Universität Bochum; Private practice of rheumatology, Hattingen, Germany, Herne, Germany, 2Ruhr-Universität Bochum, Herne, Germany, 3Elisabeth-Gruppe, Herne, Germany, Essen, Germany, 4myself, Oldenburg, Germany, 5Private rheumatology practice, Hattingen, Germany, 6Ruhr University Bochum, Bochum, Germany, 7Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany

    Background/Purpose: Axial spondyloarthritis (axSpA) is often associated with persistent pain despite effective anti-inflammatory treatment, substantially impacting patients' quality of life. Digital health applications (DiGAs) provide…
  • Abstract Number: 1248 • ACR Convergence 2025

    Patient and Clinician Perception and Use of Complementary and Alternative (CAM) Medicine for Rheumatic Disease

    Ailia Ali1, Sarah Sun1, Faryal Shaikh1, Tamiko Katsumoto2, Neha Shah3, Kimberly Trotter1 and Pankti Reid4, 1University of Chicago, Chicago, IL, 2Division of Immunology and Rheumatology, Stanford University, Millbrae, CA, 3Stanford University, Palo Alto, CA, 4University of Chicago Medical Center, Chicago, IL

    Background/Purpose: Complementary and alternative medicine (CAM) use is increasingly prevalent among patients with rheumatic diseases, yet alignment between patient practices and clinician perspectives remains poorly…
  • Abstract Number: 0730 • ACR Convergence 2025

    Levels of Disease Activity and Their Relationship With Health-Related Quality of Life In ANCA-Associated Vasculitis Patients: Data from the Almenara Vasculitis Cohort

    Victor Pimentel-Quiroz1, Alvaro Oyarce-Calderón2, Allison Figueroa-Sánchez3, Leonor León-Yaurimucha3, Rocío Gamboa-Cárdenas4, Zoila Rodríguez-Bellido5, Risto Perich-Campos6, Graciela Alarcón7 and Manuel Ugarte-Gil8, 1Universidad Científica del Sur, San Isidro, Peru, 2Hospital Nacional Guillermo Almenara Irigoyen, San Miguel, Lima, Peru, 3Universidad Científica del Sur, Lima, Peru, 4Universidad Científica del Sur, Lima, Peru, 5Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, Lima, Peru, 6Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, La Molina, Peru, 7The University of Alabama at Birmingham, Oakland, CA, 8Universidad Cientifica del Sur, Lima, Peru

    Background/Purpose: It is known that health-related quality of life (HRQoL) in patients with ANCA-associated vasculitis (AAV) is impaired. Categories of disease activity levels have been…
  • Abstract Number: 0600 • ACR Convergence 2024

    Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Reductions in Disease Impact Assessed by the Psoriatic Arthritis Impact of Disease (PsAID)-12 Questionnaire: Up to 2‑Year Results from Two Phase 3 Studies

    Laure Gossec1, Dafna Gladman2, Laura Coates3, Maarten de Wit4, Barbara Ink5, Rajan Bajracharya5, Jason Coarse6, Jérémy Lambert7 and Ana-Maria Orbai8, 1Sorbonne Université, Paris, France, 2University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom, 4Stichting Tools, Patient Research Partner, Amsterdam, Netherlands, 5UCB Pharma, Slough, United Kingdom, 6UCB Pharma, Morrisville, NC, 7UCB Pharma, Colombes, France, 8Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Bimekizumab (BKZ), a monoclonal IgG1 antibody that selectively inhibits IL‑17F in addition to IL‑17A, has demonstrated sustained reductions in disease impact of PsA, assessed…
  • Abstract Number: 1229 • ACR Convergence 2024

    Frequency of Fibromyalgia Using Validated Measures in a Sample of Patients with Psoriatic Arthritis and Impact on Disease: A Cross-Sectional Multinational Study

    avin maroof1, Nelly Ziade2, Lina El Kibbi3, Bassel Elzorkany4, Nizar Ani5, ASAL ADNAN RIDHA6, Faiq Gorial7, NABAA IHSAN JAWAD AWADH8, Nada Al Chama9, Chafika Haouichat10, Fatima Alnaimat11, Suad Mohamed Abdulla Hannawi12, Suad Hannawi13, Saed Atawnah14, HUSSEIN HALABI15, Manal Al-Mashaleh16, Ahmed Abogamal17, Rachid Bahiri18, Sahar Saad19, maha sabkar20, Krystel Aouad21, Laure Gossec22, Ihsane Hmamouchi23, nabaa abbas24, Elyes Bouajina25, Laila Aljazye26 and Laila ayoub27, and ArLAR-ARCH group, 1University of Kurdistan Hawler, Erbil, Iraq, 2Saint-Joseph University, Beirut, Lebanon, 3Division of rheumatology / Department of Medicine / Specialized Medical Center, Riyadh, Saudi Arabia, 4Private (BZRC), Cairo, Egypt, 5Baghdad College of Medicine, Baghdad, Iraq, 6Baghdad Teaching Hospital, baghdad, Iraq, 7Rheumatology Unit/Department of Medicine/ College of Medicine/ University of Baghdad, Baghdad, Iraq, 8Baghdad Teaching Hospital / Medical City, Baghdad, Iraq, 9Rheumatology Department / Ebn Al Nafiss Hospital / Damascus, Damascus, Syria, 10Djillali Bounaama university hospital, Algiers, Algeria, 11The University of Jordan, amman, Jordan, 12Rheymatology Department / Emirate Health Services / Dubai, Dubai, United Arab Emirates, 13Ministry of Health and Prevention, Dubai, United Arab Emirates, 14Al-Quds University / Alahli Hospital / Hebron ,Palestine, Hebron, Palestinian Territories, 15King Faisal Specialist Hospital / Jeddah, Jeddah, Saudi Arabia, 16Royal Medical Services, Amman, Jordan, 17Dr. Sliman Al Habib Hospital / Al-Azhar Faculty of Medicine, Dubai, United Arab Emirates, 18El Ayachi Hospital / Medical University Hospital / Rabat, Rabat, Morocco, 19King Hamad University Hospital / Assiut Medical School of Egypt, Al Sayh, Bahrain, 20King Hamad university Hospital, Arad, Bahrain, 21Saint George Hospital University Medical Center, Beirut, Lebanon, 22Sorbonne Université, Paris, France, 23Rheumatology Unit, Lalla Aicha Temara Hospital, Temara, Rabat, Morocco, 24Baghdad teaching hospital, Medical city, Baghdad, Iraq, Baghdad, Iraq, 25Farhat Hached Hospital of Sousse, Tunisia, Sousse, Tunisia, 26Tripoli / Libya, Tripoli, Libya, 27Rheumatology unit, department of internal medicine, Tripoli Central Hospital. Faculty of Medicine, University of Tripoli, Libya, Tripoli, Libya

    Background/Purpose: Fibromyalgia (FM), a chronic pain disorder, is more prevalent in psoriatic arthritis (PsA) patients, impacting quality of life and potentially leading to unnecessary treatment escalation. Cultural factors may…
  • Abstract Number: 2115 • ACR Convergence 2024

    Clinical Impact of Acute Symptomatic Vertebral Fractures in the United States: An Observational Study

    Neil Binkley1, Michele McDermott2, Eric Yeh2, Joseph Lane3, Jolenta Cheung4, Mona Amet4 and Felicia Cosman5, 1University of Wisconsin, Madison, 2Amgen Inc., Thousand Oaks, 3Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 4Adelphi Real World, Bollington, United Kingdom, 5Columbia University, College of Physicians and Surgeons, New York, NY

    Background/Purpose: To characterize pain status (frequency, severity, persistency) and effect on activities of daily living (ADLs) in patients with symptomatic vertebral fractures (VF).Methods: This was…
  • Abstract Number: PP05 • ACR Convergence 2024

    Reunion with Forgotten Relationships and Memories

    Noriko Okochi1, Eiji Oishi2, Kaoru Mitsuyama3, Emi Sorimachi3, Shiho Bando4, Yuka Hirama5, Nobuyuki Yajima6 and Masaaki Mori7, 1Rheumatic Disease and Vasculitis Support Network Japan, Tokyo, Japan, 2Rheumatic Disease and Vasculitis Support Network Japan, Yamaguchi, Japan, 3Institute of Neuropsychiatry, Tokyo, Tokyo, Japan, 4Ota-ku Children and Families Support Center, Ota-ku, Tokyo, Japan, 5Asada Ladies Clinic, Shinagawa, Japan, Tokyo, Japan, 6Showa-Universtiy of Medicine, Tokyo, Japan, 7Tokyo Medical and Dental University, Tokyo, Japan

    Background/Purpose: Paediatric rheumatic diseases are complex experiences for children.  For children whose language skills are still undeveloped, it is difficult for them to put their…
  • Abstract Number: 0614 • ACR Convergence 2024

    Bridging the Gap Between Patient’s Perception on Quality of Life and Disease Activity and Damage in Systemic Lupus Erythematous Patient

    Background/Purpose: Improving quality of life (QoL) is one of the key targets when treating systemic lupus erythematosus (SLE) patients. The Lupus impact Tracker (LIT) is…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 30
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology